J.H. Oortweg 19
About MimetasMIMETAS (Leiden, The Netherlands) is a biotechnology company developing human organ-on-a-chip technology and tissue models for testing drugs, chemicals and food components in the OrganoPlate®. The company produces and markets the OrganoPlate® culture platform, develops and validates customized disease, toxicology and transport models and ultimately will make its technology available for personalized therapy selection. The company’s unique microfluidic technology and model development know-how enables testing of compounds in high-throughput, showing better predictivity as compared to laboratory animals and conventional cell culture models. The OrganoPlate® culture platform supports 3D cell culture under continuous perfusion, with membrane-free co-culture and epithelial and endothelial tubules.
Founders: Jos Joore and Paul Vulto
Please click here for Mimetas job opportunities.
Tweets by Mimetas
7 articles with Mimetas
Biopharma and life sciences companies from around the globe provide updates on their businesses and pipelines.
3/5/2020Life sciences companies from across the globe provide updates on their businesses and pipelines.
Innovative in-vitro models ready-to-use for safety, ADME, and toxicology studies in drug development and food & nutrition research.
10/3/2019Companies from across the globe share information on their business and pipelines.
Herbert ‘Herb’ Heyneker, Chairman of the Board of Directors at Mimetas and Dutch biotech pioneer, has been honored by the Dutch Monarchy for his contributions and commitment to biotechnology in the Netherlands and Leiden.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Mimetas Develops High-Throughput Gut-On-A-Chip Technology In Collaboration With Pharmaceutical Company